Red, Near-Infrared & Far-Infrared Therapy
Red/NIR photobiomodulation and far-infrared heat · related marketing, different biology
Red + NIR photobiomodulation
Red light (~620–700 nm) and near-infrared (~700–1100 nm) are non-thermal photobiomodulation bands. The leading—but debated—mechanism is photon absorption by mitochondrial cytochrome c oxidase, nitric-oxide release, restored electron transport and short-lived ROS signaling that can influence ATP production, Nrf2 defenses and PGC-1α/TFAM biogenesis. Response is biphasic: too little may do nothing, while too much can inhibit.
Human evidence
Trials suggest modest, indication-specific benefits, not a general mitochondrial “recharge.” A 2025 meta-analysis of 19 exercise studies (672 participants) found low-certainty reductions in soreness and better 24-hour performance when PBM was used before exercise; other reviews and a small 2025 athlete trial found no meaningful strength, swelling, range-of-motion or soreness advantage. Hair-growth devices have the clearest established consumer indication. Brain, cognition and dry-AMD studies remain small or investigational, with mixed outcomes and unresolved risks.
International research
PBM work spans North American exercise and cognition pilots, European musculoskeletal studies, and multinational LIGHTSITE retinal trials. Small dementia and mild-cognitive-impairment trials report encouraging short-term signals, but reviews cannot pool the heterogeneous protocols confidently. Wavelength, irradiance, fluence, pulsing, timing and treatment site differ substantially, making results difficult to transfer from one device or use case to another.
Far-infrared is heat—not PBM
Far-infrared (~3 µm–1 mm; sauna emitters often ~5–20 µm) is absorbed mainly as heat. It does not use the red/NIR cytochrome-c-oxidase mechanism. Small, often Japanese “Waon therapy” studies report vasodilation, blood-pressure, endothelial and heart-failure signals, but mitochondrial relevance is indirect through perfusion and oxidative-stress changes. There are no established direct human mitochondrial endpoints, and “detox” claims are not supported.
Limits, safety + US status
No human study establishes durable mitochondrial-function improvement, longevity extension or “cellular-age reversal.” PBM is generally well tolerated, but can cause warmth or redness; use wavelength-rated eye protection and seek medical clearance with photosensitizing drugs, porphyria, lupus, cancer near the treatment site, pregnancy or retinal disease. Far-infrared heat adds dehydration, hypotension and cardiovascular stress. Many consumer devices are FDA 510(k)-cleared only for narrow uses such as temporary pain relief, circulation, wrinkles or hair growth—clearance is not broad disease-treatment approval.
Marketplace check · One Hype
One Hype’s One Light line ↗ includes SmartWave Prime and Nova beds using red + near-infrared light only; the company does not offer far-infrared therapy. One Hype is a commercial manufacturer/seller. Its “reverse cellular aging” language and broader performance claims were not backed by peer-reviewed trials of these specific beds in our review. Company pages support product descriptions and claims—not efficacy.